Neuphoria Therapeutics

NEUPNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$20.645 M

$3.82 -2.05%

Close of 7 Aug 2026

Revenue

$15.6M

#3078 by revenue

Earnings

-$400.0K

Loss-making

Shares outstanding

5,404,551

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#393NextCureNXTC$21.1M
#394Dare BioscienceDARE$21.0M
#395Neuphoria TherapeuticsNEUP$20.6M
#396Cellectar BiosciencesCLRB$20.5M
#397Atossa TherapeuticsATOS$20.3M

Where these numbers come from

Share counts and financials for Neuphoria Therapeutics are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.